Radiotherapy can modulate endothelial functions to promote tumor progression through mechanisms such as EndMT (Endothelial-to-Mesenchymal Transition), which increases the expression of stem cell markers like CD44v6, associated with increased osteopontin secretion in lung cancer 58. Here, SPP1 is linked to lung carcinoma.